Galapagos NV (GLPG)
NASDAQ: GLPG · IEX Real-Time Price · USD
32.95
+0.24 (0.73%)
At close: Mar 27, 2024, 4:30 PM
32.00
-0.95 (-2.88%)
Pre-market: Mar 28, 2024, 6:09 AM EDT
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $2.17 billion as of March 28, 2024. Its market cap has decreased by -12.84% in one year.
Market Cap
2.17B
Enterprise Value
-1.94B
1-Year Change
-12.84%
Ranking
Category
Stock Price
$32.95
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has increased from $1.86B to $2.17B, an increase of 16.57%. That is a compound annual growth rate of 1.74%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 26, 2024 | 2.15B | 0.09% |
Mar 25, 2024 | 2.15B | -0.25% |
Mar 22, 2024 | 2.16B | -1.97% |
Mar 21, 2024 | 2.20B | -1.59% |
Mar 20, 2024 | 2.24B | 1.77% |
Mar 19, 2024 | 2.20B | -0.12% |
Mar 18, 2024 | 2.20B | -1.65% |
Mar 15, 2024 | 2.24B | -0.53% |
Mar 14, 2024 | 2.25B | -1.30% |
Mar 13, 2024 | 2.28B | -0.32% |
Mar 12, 2024 | 2.29B | 0.18% |
Mar 11, 2024 | 2.28B | 0.52% |
Mar 8, 2024 | 2.27B | 0.03% |
Mar 7, 2024 | 2.27B | 0.06% |
Mar 6, 2024 | 2.27B | -0.20% |
Mar 5, 2024 | 2.27B | -0.43% |
Mar 4, 2024 | 2.28B | -1.28% |
Mar 1, 2024 | 2.31B | - |
Feb 29, 2024 | 2.31B | -2.69% |
Feb 28, 2024 | 2.38B | -1.80% |
Feb 27, 2024 | 2.42B | 0.66% |
Feb 26, 2024 | 2.40B | 0.72% |
Feb 23, 2024 | 2.39B | -8.28% |
Feb 22, 2024 | 2.60B | 2.17% |
Feb 21, 2024 | 2.55B | -1.90% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ginkgo Bioworks Holdings | 2.30B |
LifeStance Health Group | 2.27B |
Privia Health Group | 2.25B |
Vera Therapeutics | 2.23B |
Dyne Therapeutics | 2.19B |
Guardant Health | 2.15B |
PTC Therapeutics | 2.14B |
Tandem Diabetes Care | 2.14B |